Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the U.S. drug market. Her job, as a policy advocate at drugmaker Johnson & Johnson, was to tell patient and physician groups about the PBMs’ role in high drug prices. Armed with that knowledge, Lewandowski filed a potentially groundbreaking lawsuit in…
Colorado’s new voter-approved gun initiative has a target unlike those of previous measures meant to reduce gun violence. The tax on guns and ammunition is meant to generate revenue to support cash-strapped victim services, and it’s an open question whether it will affect firearms sales. The 6.5% tax on manufacturers and sellers — including pawnbrokers…
Among the biggest-grossing films in America in February 2002 were a war drama about American troops in Somalia (“Black Hawk Down”), an Arnold Schwarzenegger action movie (“Collateral Damage”), and a future Oscar winner about a brilliant mathematician struggling with schizophrenia (“A Beautiful Mind”). But none of these films topped the box office that month. That…
This is part 2 of Jeff Goldsmith’s history of managed care. If you missed it read Part 1 By JEFF GOLDSMITH The late 1990s crash of HMOs opened the door to a major consolidation of the health insurance market controlled largely by national and super-regional health plans. While HMOs by no means disappeared post-backlash, the…
Sara Ratner is President of integrated Programs at Nomi Health. They work with employers and health plans to connect them to a network of providers (both telehealth and physical) who accept steep discounts in return for immediate payment. The employees in turn get no co-pay/no coinsurance. In addition they have an analytics company called Artemis…
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients appeared first on MedCity News.
WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances. The post WellTheory Announces Women’s Health Program to Address Hormonal Conditions appeared first on MedCity News.
The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…
Telehealth empowers men to take control of their health in a way that is easy, confidential, and fits into their busy lifestyles. The post The Future of Men’s Healthcare: A Path to Improved Access, Outcomes, and Cost Savings appeared first on MedCity News.
Solutions like AI-powered patient intake offer a tangible ROI by streamlining administrative tasks, reducing errors, and improving care quality. The post Let’s Rethink AI — Patient Intake Is the Perfect Place to Start appeared first on MedCity News.